CIENCIASMEDICASNEWS: Molecular Cancer

jueves, 22 de febrero de 2018

Articles

Content Type:Review
| 22 February 2018
Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer
Authors:Hongyu Liu, Cheng Lei, Qin He, Zou Pan, Desheng Xiao and Yongguang Tao
Content Type:Research
| 21 February 2018
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1
Authors:Chen-Hong Ding, Chuan Yin, Shi-Jie Chen, Liang-Zhi Wen, Kai Ding, Shu-Juan Lei, Jin-Pei Liu, Jian Wang, Kai-xian Chen, Hua-liang Jiang, Xin Zhang, Cheng Luo and Wei-Fen Xie
Content Type:Review
| 19 February 2018
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
Authors:Shaocong Wu and Liwu Fu
Content Type:Review
| 19 February 2018
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
Authors:Emily K. Kleczko and Lynn E. Heasley
Content Type:Review
| 19 February 2018
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Authors:Yazhuo Zhang, Mengfang Xia, Ke Jin, Shufei Wang, Hang Wei, Chunmei Fan, Yingfen Wu, Xiaoling Li, Xiayu Li, Guiyuan Li, Zhaoyang Zeng and Wei Xiong